Home/ Supplements/ Calcium/ Multivitamin

Multivitamin

product on market Capsule Shredz Supplements Safety: 97/100
97/100

This product looks safe

  • Vitamin B3: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)
  • 62% of ingredients have research evidence
C Label Compliance Grade

What the Evidence Says

AI-generated · Qwen 3.6 · methodology

Calcium and magnesium citrates support bone health and muscle function, while vitamins A and B-complex aid metabolic processes and immune support. There is strong evidence for the efficacy of these essential micronutrients in maintaining general health. The product maintains a high safety profile based on the provided score.

AI-generated summary based on research evidence. Not medical advice.

Alerts

Safety Alerts

Vitamin B3: 500mg is 14.3× the Tolerable Upper Intake Level (35mg)

Label

Product Label

Label for Multivitamin
Open Full PDF View on NIH DSLD →
Details

Label Data

2 Capsule(s)
Serving Size
30
Servings
Other Combinations
Product Type
62%
Evidence Coverage
Ingredients

Supplement Facts — Evidence Check

48 mg (1% DV)
Market median: 500.0mg (266 products) 441 studies (A:25, B:228)
63 mg (2.38% DV)
Within RDA (0.1× RDA)
Vitamin A
5000 IU (10000% DV)
120 mcg (10% DV)
Within RDA (0.1× RDA) 76 studies (A:0, B:33)
160 mcg (12.23% DV)
Within RDA (0.1× RDA) 13 studies (A:0, B:1)
500 mg (3125% DV)
Exceeds UL by 14.3× (UL: 35 mg) 196 studies (A:5, B:63)
2 mg (40% DV)
Within RDA (0.4× RDA) 2 studies — no high-quality reviews
5 mg (383.08% DV)
3.8× RDA — above typical dose (UL: 100 mg) 114 studies (A:3, B:35)
3 mcg (125% DV)
1.3× RDA — within safe limits 139 studies (A:1, B:44)
Vitamin C
400 mg (444.44% DV)
400 IU (66.67% DV)
Within RDA (0.7× RDA) 608 studies (A:16, B:251)
40 IU (133.33% DV)
1.8× RDA — within safe limits 179 studies (A:3, B:90)
SHREDZ(R) Proprietary Blend
512 mg

Other Ingredients

Maltodextrin Magnesium Stearate Gelatin Titanium Dioxide FD&C Yellow #6 FD&C Red #3
Claims

Label Claims — Verification

Unverified All Other
Unverified Structure/Function
Info

Product Information

Directions for Use

Directions: Take two (2) capsules daily.

Warnings & Precautions

Do not consume synephrine or caffeine from other sources, including but not limited to, coffee, tea, soda and other dietary supplements or medications containing phenylephrine or caffeine.

WARNING: NEVER EXCEED RECOMMENDED DOSAGE

Not for use by persons under age 18.

Do not use for more than 8 weeks. Consult your physician prior to use if you have a medical condition, including by not limited to, heart, liver, kidney, or thyroid disease, psychiatric disorders, difficulty urinating, diabetes, high blood pressure, cardiac arrhythmia, recurrent headaches, enlarged prostate or glaucoma. Discontinue 2 weeks prior to surgery or if you experience rapid heart beat, dizziness, severe headaches or shortness of breath.

KEEP OUT OF REACH OF CHILDREN.

Do not use if pregnant or nursing.

Formulation Notes

Contains caffeine.

Additional Information

ALPHA

INSPECTED GOOD MANUFACTURING PRACTICES cGMP FACILITY

As individuals vary so may results from using this product. This product contains ingredients of international & domestic origin.

MADE IN THE USA

Metadata

Product Details

UPC / SKU8 11207 02138 1
DSLD Entry Date2014-04-25
Product TypeOther Combinations
FormCapsule
DSLD ID32008
Data Updated2026-04-11
Research

Research Evidence

511
Research Sources
57
Avg Quality
266
Meta Analysis
95
Systematic Review
76
Rct
49
Clinical Trial
12
Guideline
4
Regulatory Source
2
Cochrane Review
2
Other
2
Narrative Review
1
Openfda Safety
A Phosphate binders for preventing and treating chronic kidney disease-mineral and bone disorder (CKD-MBD)
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2024 PubMed DOI
A Calcium supplementation (other than for preventing or treating hypertension) for improving pregnancy and infant outcomes
Meta Analysis The Cochrane database of systematic reviews 2015 PubMed DOI
A Vitamin and mineral supplementation for maintaining cognitive function in cognitively healthy people in mid and late life
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Calcium supplementation during pregnancy for preventing hypertensive disorders and related problems
Meta Analysis The Cochrane database of systematic reviews 2025 PubMed DOI
A First-line drugs for hypertension
Meta Analysis The Cochrane database of systematic reviews 2018 PubMed DOI
A Dietary calcium supplementation for preventing colorectal cancer and adenomatous polyps
Systematic Review The Cochrane database of systematic reviews 2008 PubMed DOI
A Calcium and vitamin D for increasing bone mineral density in premenopausal women
Systematic Review The Cochrane database of systematic reviews 2023 PubMed DOI
A Beta-blockers for hypertension
Meta Analysis The Cochrane database of systematic reviews 2017 PubMed DOI
A Calcium channel blockers versus other classes of drugs for hypertension
Systematic Review The Cochrane database of systematic reviews 2021 PubMed DOI
View all evidence for Calcium →
Compare

Similar Products

View all Calcium products →

This product page is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider before taking any supplement.